Description: Sinai Health System and the University of Toronto are seeking applications for a Clinician Scientist to become the inaugural Chair in Rheumatoid Arthritis Excellence and Discovery at the Sinai Health System. The effective start date of the appointment is negotiable but could be as early as Mar 1, 2025. This position is for a 5-year term, and renewable following a successful review.
The Division of Rheumatology is seeking to advance the frontiers of rheumatoid arthritis (RA) care, research, innovation, and advocacy. Sinai Health has been long recognized as an international centre of excellence in RA and our program has made discoveries and multiple contributions over the years. In a ground-breaking approach, we aim to seamlessly integrate our multimodal expertise in RA with the ultimate goal of enhancing patient outcomes. Aligned with Sinai Health System's dedication to leading in the management of complexity, the Chair in Rheumatoid Arthritis Excellence and Discovery will spearhead initiatives focused on promoting advances in person-centered care. In addition, the Chair will be part of a large, academically successful rheumatology unit with an active clinical role aligned with divisional and departmental priorities. The Division of Rheumatology incorporates exemplary clinical care with an active clinical research program and a strong presence in medical education at the internal medicine, subspecialty, and fellowship levels.
The successful candidate must hold or be eligible for a full-time clinical academic appointment at the rank of Associate or Full Professor at the University of Toronto. Applicants must hold an MD degree and have successfully completed approved postgraduate subspecialty training in rheumatology resulting in recognized certification as a rheumatologist. They must have, or be eligible for, licensure in Ontario. Candidates should have graduate training in an area of scholarship that aligns with their research and scholarly endeavours. The successful candidate will report directly to the University of Toronto and Sinai Health System leadership for the Division of Rheumatology and the Department of Medicine.
The successful applicant should have leadership experience and an established track record of achievement in collaborative clinical/basic/translational research and creative professional activity. These attributes should be supported by experience in clinical teaching and supervision. The successful applicant should be a national / international expert in his/her field. They will be expected to develop a successful strategic plan and fundraising program for RA research within an academic health sciences hospital. Academic excellence will be assessed by review of applicants’ peer-reviewed publications, research grants, invitations to, and presentations at, significant conferences and events, awards, and accolades.
Academic rank, job description, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. The successful candidate would also have a primary clinical researcher appointment at the Lunenfeld-Tanenbaum Research Institute. Remuneration and start-up funding is multi-sourced and includes base salary support, commensurate with the job description, funding through the Alternate Funding Plan, the funds from the endowed Chair and clinical (fee-for-service) billings. The Chair is endowed at $3 Million and is resourced to provide annual revenues to be used for both direct Chair support and scholarly activities, with expenditures to be approved by the Hospital Chief of Rheumatology.
Closing date for applications: Nov 15, 2024. Interested individuals should send a copy of their curriculum vitae, the names and contact information of three referees, and a cover letter describing relevant experience and reason for interest in this role to:
Dr. Nigil Haroon CAUTION: This ad is “posted only” to the U of T affiliated hospital job board. Please see the information directly above for the application instructions; applications submitted via the "Apply Now" button on this page will NOT be considered for this position.
For more information about the Division of Rheumatology, please visit https://deptmedicine.utoronto.ca/rheumatology
The University of Toronto has one of the most concentrated biomedical research communities in the world, including 9 academic hospital research institutes that are fully affiliated with the University. Sinai Health System (SHS) is an academic health sciences centre affiliated with the University of Toronto (U of T) and situated in the downtown core of this large multicultural center. SHS comprises Mount Sinai Hospital (MSH), Hennick Bridgepoint Hospital, the Lunenfeld Tanenbaum Research Institute and the Circle of Care. MSH is an internationally recognized 442-bed acute care academic health sciences centre renowned for women’s and infants’ health, chronic disease management, specialized cancer care, emergency medicine and geriatrics.
The Lunenfeld-Tanenbaum Research Institute is an internationally renowned facility with expertise in signalling networks, cancer and developmental biology, structural biology, imaging, high throughput screening and proteomics. With numerous discoveries in basic and applied research in cancer, developmental biology, stem cell biology, diabetes, genetic disorders and women’s and infants’ health, the Lunenfeld-Tanenbaum Research Institute is committed to excellence in health research and the training of young investigators. The Institute provides a research-intensive environment with modern and innovative core facilities that include proteomics, next-generation sequencing, single-cell platforms, robotics and imaging that drive technology development and are housed in the Network Biology Collaborative Centre. Sinai Health is also the home of The Centre for Phenogenomics, a state-of-the-art national facility for mouse models.
All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority. Diversity StatementThe University of Toronto embraces Diversity and is building a culture of belonging that increases our capacity to effectively address and serve the interests of our global community. We strongly encourage applications from Indigenous Peoples, Black and racialized persons, women, persons with disabilities, and people of diverse sexual and gender identities. We value applicants who have demonstrated a commitment to equity, diversity and inclusion and recognize that diverse perspectives, experiences, and expertise are essential to strengthening our academic mission. Accessibility StatementThe University strives to be an equitable and inclusive community, and proactively seeks to increase diversity among its community members. Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission.
|